Average Co-Inventor Count = 2.67
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Axys Pharmaceuticals, Inc. (12 from 40 patents)
2. Prototek, Inc. (3 from 11 patents)
3. Aventis Pharmaceuticals Inc. (2 from 207 patents)
4. Pharmacyclics, Inc. (2 from 193 patents)
5. Merck + Co., Inc. (1 from 4,770 patents)
6. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
7. Merck Frosst Canada, Inc. (1 from 212 patents)
8. Merck Canada Inc. (1 from 40 patents)
9. Arris Pharmaceutical Corporation (1 from 11 patents)
10. Arris Pharmaceuticals (1 from 1 patent)
19 patents:
1. 8772336 - Cathepsin cysteine protease inhibitors
2. 8318748 - Cathepsin cysteine protease inhibitors
3. 8067395 - Inhibitors of tyrosine kinases and uses thereof
4. 7973037 - Cathepsin cysteine protease inhibitors
5. 7625880 - Inhibitors of tyrosine kinases and uses thereof
6. 7196099 - Compounds and compositions as cathepsin inhibitors
7. 7030116 - Compounds and compositions as cathepsin inhibitors
8. 7012075 - Cathepsin cysteine protease inhibitors
9. 6900237 - Sulfonamide compounds as protease inhibitors
10. 6593327 - Compounds and compositions as protease inhibitors
11. 6506733 - Compounds and compositions as protease inhibitors
12. 6476026 - Compounds and compositions as protease inhibitors
13. 6287840 - Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups
14. 6030946 - Reversible cysteine protease inhibitors
15. 5976858 - Irreversible cysteine protease inhibitors containing vinyl groups